Reuters
@Reuters·4.2M subscribers·86.9K videos
AstraZeneca aims for $80 bln in total revenue by 2030 | REUTERS
Posted
May 21, 2024
Views
766
Likes
10
Engagement
1.31%
May 21, 2024
766
10
1.31%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:04Now PlayingAstraZeneca aims to grow revenue by 75% to $80 billion by 2030, boosted by the expected launch of 20 new medicines and through growth in its existing oncology, biopharmaceuticals and rare disease portfolio
#News #astrazeneca #pharmaceutical #Reuters #Newsfeed
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
